BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue22,561,00020,776,00019,427,00016,560,000
Cost of revenue6,490,0005,945,0004,948,0003,825,000
Gross profit16,071,00014,831,00014,479,00012,735,000
Operating expenses
Research development5,131,0004,894,0004,477,0004,037,000
Selling general and administrative4,522,0004,749,0004,907,0004,831,000
Non-recurring----
Others----
Total operating expenses16,143,00015,588,00014,332,00012,693,000
Operating income or loss6,418,0005,188,0005,095,0003,867,000
Income from continuing operations
Total other income/expenses net-450,000-57,000820,000-1,790,000
Earnings before interest and taxes6,418,0005,188,0005,095,0003,867,000
Interest expense-183,000-196,000-167,000-184,000
Income before tax5,968,0005,131,0005,915,0002,077,000
Income tax expense1,021,0004,156,0001,408,000446,000
Minority interest96,000106,000170,000158,000
Net income from continuing ops4,947,000975,0004,507,0001,631,000
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income4,920,0001,007,0004,457,0001,565,000
Preferred stock and other adjustments----
Net income applicable to common shares4,920,0001,007,0004,457,0001,565,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes